#OpenAccess – it’s up to all of us!
Synthetic-biology company pushes open-source models.
Open access to validated molecular components is crucial to the field’s success, says Drew Endy, a synthetic biologist at Stanford University in California. Endy says that synthetic biologists are similar to software engineers, with the genetic code as their programming language. The software industry has favoured open-source approaches and copyright protections, because inventions often come faster than patents can be acquired. The same holds for synthetic biology (...).
International Open Access Week 2012 Events in Paris, Oct. 23rd and 25th 2012. For participation register here.
More information on www.openaccessweek-mysciencework.com